Young investigator challenge: Cadherin-17 and SATB2 in cytology specimens: Do these new immunostains help in differentiating metastatic colorectal adenocarcinoma from adenocarcinomas of other origins?

Cancer Cytopathology

Volumn 123, Issue 12, 2015, Pages 706-712

  Brandler, Tamar C ^a   Jelloul, Fatima Zahra ^a   Soto, Daniel ^a   Das, Kasturi ^a   Rosen, Lisa ^a   Bhuiya, Tawfiqul A ^a  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

cadherin 17; colorectal adenocarcinoma; cytology; immunocytochemistry; SATB homeobox 2 (SATB2)

Indexed keywords

CADHERIN; CADHERIN 17; CYTOKERATIN 20; CYTOKERATIN 7; DNA BINDING PROTEIN; SATB2 PROTEIN; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG; CDH17 PROTEIN, HUMAN; MATRIX ATTACHMENT REGION BINDING PROTEIN; SATB2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; BREAST ADENOCARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; METASTATIC COLORECTAL ADENOCARCINOMA; OVARY CARCINOMA; PANCREAS ADENOCARCINOMA; PREDICTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SENSITIVITY AND SPECIFICITY; ADENOCARCINOMA; BIOSYNTHESIS; COLORECTAL TUMOR; CYTODIAGNOSIS; NEOPLASM METASTASIS; PATHOLOGY; SECONDARY;

ADENOCARCINOMA; BIOMARKERS, TUMOR; CADHERINS; COLORECTAL NEOPLASMS; CYTODIAGNOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX ATTACHMENT REGION BINDING PROTEINS; NEOPLASM METASTASIS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 84962298796     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21644     Document Type: Article

References (14)

1. Su MC, Yuan RH, Lin CY, Jeng YM,. Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system. Mod Pathol. 2008; 21: 1379-1386.
2. Ordonez NG,. Cadherin 17 is a novel diagnostic marker for adenocarcinomas of the digestive system. Adv Anat Pathol. 2014; 21: 131-137.
3. Panarelli NC, Yantiss RK, Yeh MM, Liu Y, Chen YT,. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2. Am J Clin Pathol. 2012; 138: 211-222.
4. Conner JR, Hornick JL,. Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry. Adv Anat Pathol. 2015; 22: 149-167.
5. Dragomir A, de Wit M, Johansson C, Uhlen M, Ponten F,. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study. Am J Clin Pathol. 2014; 141: 630-638.
6. Magnusson K, de Wit M, Brennan DJ, et al., SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol. 2011; 35: 937-948.
7. Ordonez NG,. SATB2 is a novel marker of osteoblastic differentiation and colorectal adenocarcinoma. Adv Anat Pathol. 2014; 21: 63-67.
8. Lin F, Shi J, Zhu S, et al., Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine. Arch Pathol Lab Med. 2014; 138: 1015-1026.
9. DeLong ER, DeLong DM, Clarke-Pearson DL,. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44: 837-845.
10. Werling RW, Yaziji H, Bacchi CE, Gown AM,. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003; 27: 303-310.
11. Rao Q, Williamson SR, Lopez-Beltran A, et al., Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers. Mod Pathol. 2013; 26: 725-732.
12. Yakirevich E, Magi-Galluzzi C, Grada Z, Lu S, Resnick MB, Mangray S,. Cadherin 17 is a sensitive and specific marker for metanephric adenoma. Am J Surg Pathol. 2015; 39: 479-486.
13. Wang S, Zhou J, Wang XY, et al., Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J Pathol. 2009; 219: 114-122.
14. Eberhard J, Gaber A, Wangefjord S, et al., A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer. Br J Cancer. 2012; 106: 931-938.